{"id":229049,"title":"Update: Requirements for Tuberculosis Screening of Healthy Volunteers in Phase I Clinical Trials involving Immunosuppressant Drugs or Drugs with Immunosuppressant Properties - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-19","captureTimestamp":"2025-04-19T00:15:57.753000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/clinical-trials/update-clinical-trial-sponsors-requirements-tuberculosis-screening-healthy-volunteers-phase-1-clinical-trials-involving-immunosuppressant-drugs.html?wbdisable=false","snippet":"Update: Requirements for Tuberculosis Screening of Healthy Volunteers in Phase I Clinical Trials involving Immunosuppressant Drugs or Drugs with Immunosuppressant Properties - Canada.ca Skip to main content Skip to \"About government\" Language selection Français fr / Gouvernement…","rawSnapshotUrl":"/api/snapshots/raw/229049","browseUrl":"https://replay.healtharchive.ca/job-1/20250419001557/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/clinical-trials/update-clinical-trial-sponsors-requirements-tuberculosis-screening-healthy-volunteers-phase-1-clinical-trials-involving-immunosuppressant-drugs.html?wbdisable=false#ha_snapshot=229049","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}